title: Intra-arterial chemotherapy for advanced retinoblastoma: is the time right for a prospective clinical trial?
authors.forename: Marc H
authors.initials: MH
authors.lastname: Levin
authors.forename: Dan S
authors.initials: DS
authors.lastname: Gombos
authors.forename: Joan M
authors.initials: JM
authors.lastname: O'Brien
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects*; D005134:Eye Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial / Q000009:adverse effects*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D009366:Neoplasm Seeding; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy*; D014822:Vitreous Body / Q000187:drug effects*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan